Literature DB >> 21270214

Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis.

Marie Machouart1, Dea Garcia-Hermoso, Alexandre Rivier, Noura Hassouni, Emilie Catherinot, Alexandra Salmon, Anne Debourgogne, Hélène Coignard, Marc Lecuit, Marie-Elisabeth Bougnoux, Stéphane Blanche, Olivier Lortholary.   

Abstract

We report two cases of invasive infections due to Geosmithia argillacea, an emerging mold, in patients with chronic granulomatous disease receiving prolonged azole antifungal prophylaxis. One patient died despite receiving a combination of four antifungals, and the other developed cerebral and medullary lesions under a combination of caspofungin, posaconazole, terbinafine, and gamma interferon.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21270214      PMCID： PMC3122873          DOI： 10.1128/JCM.02456-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis.

Authors:  R C Barton; A M Borman; E M Johnson; J Houbraken; R P Hobson; M Denton; S P Conway; K G Brownlee; D Peckham; T W R Lee
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

2.  Disseminated Geosmithia argillacea infection in a German shepherd dog.

Authors:  David C Grant; Deanna A Sutton; Christina A Sandberg; Ronald D Tyler; Elizabeth H Thompson; Anna M Romanelli; Brian L Wickes
Journal:  Med Mycol       Date:  2009-03       Impact factor: 4.076

3.  Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France.

Authors:  Julien Beauté; Gaëlle Obenga; Loïc Le Mignot; Nizar Mahlaoui; Marie-Elisabeth Bougnoux; Richard Mouy; Marie-Anne Gougerot-Pocidalo; Vincent Barlogis; Felipe Suarez; Fanny Lanternier; Olivier Hermine; Marc Lecuit; Stéphane Blanche; Alain Fischer; Olivier Lortholary
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

4.  Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis.

Authors:  Sandrine Giraud; Marc Pihet; Bienvenue Razafimandimby; Jacqueline Carrère; Nicolas Degand; Laurent Mely; Loïc Favennec; Eric Dannaoui; Jean-Philippe Bouchara; Alphonse Calenda
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

Review 5.  Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus.

Authors:  John Dotis; Emmanuel Roilides
Journal:  Int J Infect Dis       Date:  2004-03       Impact factor: 3.623

6.  Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.

Authors:  Baldassarre Martire; Roberto Rondelli; Annarosa Soresina; Claudio Pignata; Teresa Broccoletti; Andrea Finocchi; Paolo Rossi; Marco Gattorno; Marco Rabusin; Chiara Azzari; Rosa M Dellepiane; Maria C Pietrogrande; Antonino Trizzino; Paolo Di Bartolomeo; Silvana Martino; Luigi Carpino; Fausto Cossu; Franco Locatelli; Rita Maccario; Paolo Pierani; Maria C Putti; Achille Stabile; Luigi D Notarangelo; Alberto G Ugazio; Alessandro Plebani; Domenico De Mattia
Journal:  Clin Immunol       Date:  2007-11-26       Impact factor: 3.969

7.  Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa.

Authors:  Dea Garcia-Hermoso; Damien Hoinard; Jean-Charles Gantier; Frédéric Grenouillet; Françoise Dromer; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

8.  Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery.

Authors:  Caspar J Hodiamont; Koert M Dolman; Ineke J M Ten Berge; Willem J G Melchers; Paul E Verweij; Dasja Pajkrt
Journal:  Med Mycol       Date:  2008-12-19       Impact factor: 4.076

9.  Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous disease.

Authors:  Roel Dekkers; Paul E Verweij; Corry M R Weemaes; René S V M Severijnen; Johan H J M Van Krieken; Adilia Warris
Journal:  Med Mycol       Date:  2008-03-10       Impact factor: 4.076

10.  Clinicopathologic and diagnostic imaging characteristics of systemic aspergillosis in 30 dogs.

Authors:  R M Schultz; E G Johnson; E R Wisner; N A Brown; B A Byrne; J E Sykes
Journal:  J Vet Intern Med       Date:  2008 Jul-Aug       Impact factor: 3.333
View more
  14 in total

Review 1.  Name Changes for Fungi of Medical Importance, 2012 to 2015.

Authors:  David W Warnock
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients.

Authors:  Abdelmounaim Mouhajir; Olivier Matray; Sandrine Giraud; Laurent Mély; Christophe Marguet; Isabelle Sermet-Gaudelus; Solène Le Gal; Franck Labbé; Christine Person; Françoise Troussier; Jean-Jacques Ballet; Gilles Gargala; Rachid Zouhair; Marie-Elisabeth Bougnoux; Jean-Philippe Bouchara; Loïc Favennec
Journal:  J Clin Microbiol       Date:  2016-09-07       Impact factor: 5.948

3.  Kinetics of Radiological Response of Thoracic Invasive Fungal Disease in Chronic Granulomatous Disease.

Authors:  Romain Guery; Benjamin Subran; Arnaud Lefevre; Fanny Lanternier
Journal:  J Clin Immunol       Date:  2017-09-01       Impact factor: 8.317

4.  In Vitro Activity of Isavuconazole against Rasamsonia Species.

Authors:  J Steinmann; S Dittmer; J Houbraken; J Buer; P-M Rath
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

5.  Rasamsonia argillacea pulmonary and aortic graft infection in an immune-competent patient.

Authors:  Jeffrey B Doyon; Deanna A Sutton; Pierre Theodore; Gurmohan Dhillon; Kirk D Jones; Elizabeth H Thompson; Jianmin Fu; Brian L Wickes; Jane E Koehler; Brian S Schwartz
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

6.  Taxonomy and antifungal susceptibility of clinically important Rasamsonia species.

Authors:  J Houbraken; S Giraud; M Meijer; S Bertout; J C Frisvad; J F Meis; J P Bouchara; R A Samson
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

7.  Identification and Antifungal Susceptibility of Penicillium-Like Fungi from Clinical Samples in the United States.

Authors:  Marcela Guevara-Suarez; Deanna A Sutton; José F Cano-Lira; Dania García; Adela Martin-Vicente; Nathan Wiederhold; Josep Guarro; Josepa Gené
Journal:  J Clin Microbiol       Date:  2016-06-08       Impact factor: 5.948

8.  Paravertebral mushroom: identification of a novel species of Phellinus as a human pathogen in chronic granulomatous disease.

Authors:  Suk See De Ravin; Mark Parta; Deanna A Sutton; Brian L Wickes; Elizabeth H Thompson; Nathan P Wiederhold; Karen K Nakasone; Meghna Alimchandani; Amy OConnell; Luigi Notarangelo; Elizabeth Kang; Harry L Malech; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

9.  Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient.

Authors:  Christophe Marguet; Loïc Favennec; Olivier Matray; Sébastien Bertout; Sandrine Giraud; Laure Couderc; Rachid Zouhair; Christine Leguillon; Gilles Gargala; Jean-J Jacques Ballet; Jean-Philippe Bouchara
Journal:  Med Mycol Case Rep       Date:  2012-09-12

10.  Isolation and identification of Geosmithia argillacea from a fungal ball in the lung of a tuberculosis patient.

Authors:  Ji Yeon Sohn; Mi-Ae Jang; Jang Ho Lee; Kyung Sun Park; Chang-Seok Ki; Nam Yong Lee
Journal:  Ann Lab Med       Date:  2013-02-21       Impact factor: 3.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.